Novartis Oncology Software Engineering Manager Salaries in Wilmington, DE
The average Novartis Oncology Software Engineering Manager in Wilmington, DE earns an estimated $135,599 annually, which includes an estimated base salary of $124,599 with a $11,000 bonus. Novartis Oncology's Software Engineering Manager compensation is $23,973 less than the US average for a Software Engineering Manager. Software Engineering Manager salaries at Novartis Oncology in Wilmington, DE can range from $82,000 - $167,000.
In Wilmington, DE, The Engineering Department at Novartis Oncology earns $1,831 more on average than the Marketing Department.
Last updated 3 years ago.
- $124,599
- avg. base
- $11,000
- avg. bonus
Software Engineering Manager Salaries at Novartis Oncology
In Wilmington, DE, Software Engineering Managers earn $458 more than Data Scientists, and $13,267 less than Sales Engineers.
Compensation at Novartis Oncology by Department
In Wilmington, DE, The Engineering Department averages $1,831 more than the Marketing Department, and $129 less than the Business Development Department
Software Engineering Manager Compensation by Gender (All Companies)
The average female Software Engineering Manager at companies similar size to Novartis Oncology reported making $164,584, while the average male Software Engineering Manager at similar sized companies reported making $184,820.
Software Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Software Engineering Manager at companies similar size to Novartis Oncology reported making $191,271, while the average Native American Software Engineering Manager at similar sized companies reported making $155,000.
How Software Engineering Managers at Novartis Oncology Rate Their Compensation
The majority of Software Engineering Managers at Novartis Oncology believe they're not compensated fairly. 100% of Software Engineering Managers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
